DECREASE OF VARICELLA ZOSTER VIRUS - ASSOCIATED PAEDIATRIC HOSPITALISATIONS AND COMPLICATIONS IN BAVARIA AFTER RECOMMENDATION FOR ROUTINE VARICELLA VACCINATION
ESPID Education. Streng A. 06/07/11; 7703 Disclosure(s)(s): This investigator-initiated study was financially supported by GlaxoSmithKline Biolgoicals, Rixensart (Belgium). A. Streng, V. Grote and J.G. Liese received research grants, honorary fees for presenting at sponsored symposia, remuneration for consulting activities, or reimbursement for travel expenses from GlaxoSmithKline or from other pharmaceutical companies.
Dr. Andrea Streng
Dr. Andrea Streng

This content is available to ESPID members only


Click here for more information or if you are considering becoming an ESPID member.

Discussion Forum (0)
Rate & Comment (0)
Code of conduct/disclaimer available in General Terms & Conditions

By clicking “Accept Terms & all Cookies” or by continuing to browse, you agree to the storing of third-party cookies on your device to enhance your user experience and agree to the user terms and conditions of this learning management system (LMS).

Cookie Settings
Accept Terms & all Cookies